Ukulahlekelwa isisindo Semaglutide CAS 910463-68-2
Incazelo
I-Semaglutide(910463-68-2) umuthi wokulwa nesifo sikashukela othengiswa ngaphansi kwamagama emikhiqizo afana ne-Ozempic, Wegovy, ne-Rybelsus.Isetshenziselwa ukwelapha isifo sikashukela sohlobo 2 nokuphatha isisindo esingamahlalakhona.Umuthi usebenza ngokufana ne-glucagon-like peptide-1 (GLP-1) ngokwandisa ukukhiqizwa kwe-insulin, okuholela ekuthuthukisweni kwemetabolism kashukela.Isatshalaliswa njengomjovo we-metered subcutaneous esibayeni esigcwaliswe ngaphambili, noma njengefomu lomlomo.Enye yezinzuzo zayo kunezinye izidakamizwa ze-antidiabetic ukuthi inesikhathi eside sokusebenza, ngakho-ke, umjovo weviki kanye kuphela owanele.
Isebenzisa
I-Semaglutide isetshenziselwa ukuphatha uhlobo lwe-2 yesifo sikashukela kanye nezinguquko zendlela yokuphila, njengemikhawulo yokudla kanye nokusebenza ngokomzimba okwandisiwe.Isebenza futhi ngokunciphisa ukuhamba kokudla esiswini futhi ingase yehlise isifiso sokudla futhi ibangele ukuncipha kwesisindo.Akukaze kube nemibiko eshicilelwe ye-hepatotoxicity ebizwa ngokuthi i-semaglutide therapy.
Indlela yokwenza
I-Semaglutide i-glucagon-like peptide-1 receptor agonist.Yandisa ukukhiqizwa kwe-insulin, ihomoni elehlisa izinga likashukela egazini.Kubukeka futhi kuthuthukisa ukukhula kwama-β-cell ku-pancreas, okuyizindawo zokukhiqizwa kwe-insulin.Iphinde ivimbele i-glucagon, okuyi-hormone ekhulisa ushukela wegazi.Ukwengeza kunciphisa ukudla ngokunciphisa isifiso sokudla futhi kubambezele ukugaya esiswini.Ngale ndlela kunciphisa amafutha omzimba.
Umsebenzi Webhayoloji
I-Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), i-glucagon-like peptide 1 (GLP-1) analogue esebenza isikhathi eside, iyi-analogue ye-GLP-1 receptor enamandla okwelapha uhlobo 2 lwesifo sikashukela (T2DM).
Ukupakisha Nokulethwa
